These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12687067)

  • 1. Regulation of Classical Pathway of Complement Activation by Interferons.
    Lebedeva TV; Kozlov LV
    Russ J Immunol; 1997 Jul; 2(2):129-134. PubMed ID: 12687067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of formation of complement C5-convertase].
    Kozlov LV; Lebedeva TV
    Bioorg Khim; 1998 May; 24(5):350-5. PubMed ID: 9661788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the C3b-binding site on C4b-binding protein in regulating classical pathway C5 convertase.
    Rawal N; Pangburn MK
    Mol Immunol; 2007 Feb; 44(6):1105-14. PubMed ID: 16979240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway.
    Møller-Kristensen M; Thiel S; Sjöholm A; Matsushita M; Jensenius JC
    Int Immunol; 2007 Feb; 19(2):141-9. PubMed ID: 17182967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation and disease: protective effects of hyperbilirubinaemia.
    Basiglio CL; Arriaga SM; Pelusa F; Almará AM; Kapitulnik J; Mottino AD
    Clin Sci (Lond); 2009 Oct; 118(2):99-113. PubMed ID: 19807696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.
    Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE
    Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
    Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
    Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The many effects of complement C3- and C5-binding proteins in renal injury.
    Puri TS; Quigg RJ
    Semin Nephrol; 2007 May; 27(3):321-37. PubMed ID: 17533009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the mechanisms of anti-complement activity in Ixodes ricinus ticks.
    Lawrie CH; Sim RB; Nuttall PA
    Mol Immunol; 2005 Jan; 42(1):31-8. PubMed ID: 15488941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of the interaction of C1q with immunoglobulins and the classical pathway of complement activation by steroids and triterpenoids sulfates.
    Bureeva S; Andia-Pravdivy J; Symon A; Bichucher A; Moskaleva V; Popenko V; Shpak A; Shvets V; Kozlov L; Kaplun A
    Bioorg Med Chem; 2007 May; 15(10):3489-98. PubMed ID: 17383882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway.
    Carlsson F; Sandin C; Lindahl G
    Mol Microbiol; 2005 Apr; 56(1):28-39. PubMed ID: 15773976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
    Galebskaia LV; Solovtsova IL; Riumina EV
    Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformationally altered hyaluronan restricts complement classical pathway activation by binding to C1q, C1r, C1s, C2, C5 and C9, and suppresses WOX1 expression in prostate DU145 cells.
    Hong Q; Kuo E; Schultz L; Boackle RJ; Chang NS
    Int J Mol Med; 2007 Jan; 19(1):173-9. PubMed ID: 17143562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition.
    Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Mollnes TE
    Ann Thorac Surg; 2004 Jul; 78(1):38-44; discussion 44-5. PubMed ID: 15223398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complement activation and inflammation].
    Abe M
    Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
    Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
    J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's sarcoma-associated herpes virus complement control protein: KCP--complement inhibition and more.
    Mark L; Spiller OB; Villoutreix BO; Blom AM
    Mol Immunol; 2007 Jan; 44(1-3):11-22. PubMed ID: 16905191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement amplification revisited.
    Lutz HU; Jelezarova E
    Mol Immunol; 2006 Jan; 43(1-2):2-12. PubMed ID: 16023211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood.
    Brekke OL; Christiansen D; Fure H; Fung M; Mollnes TE
    J Leukoc Biol; 2007 Jun; 81(6):1404-13. PubMed ID: 17389579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.